ArticleJournal of advanced research2023

Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy.

Abdullah Al-Dhfyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.